Reoptimization of human kinase inhibitors for the treatment of neglected tropical diseases
Neglected tropical diseases (NTDs) represent a major burden to the tropical and sub-tropical countries. Despite the large number of people impacted by these diseases, the investment from the pharmaceutical industry has not been proportionate to the problem at hand. This is due to a myriad of factors...
| Published: |
|
|---|---|
| Online Access: | http://hdl.handle.net/2047/D20321213 |